Citation Impact
Citing Papers
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits
2009 Standout
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2009 StandoutScience
p300 Interacts with the N- and C-terminal Part of PPARγ2 in a Ligand-independent and -dependent Manner, Respectively
1999
Heterogeneous Expression and Functions of Androgen Receptor Co-Factors in Primary Prostate Cancer
2002
From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells
1999
Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1
1999
The glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain
2000
Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain
2001
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Cancer chemoprevention with dietary phytochemicals
2003 Standout
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Activation of the Androgen Receptor N-terminal Domain by Interleukin-6 via MAPK and STAT3 Signal Transduction Pathways
2002
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Prostate cancer in Asian men
2014
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
The Androgen Receptor Recruits Nuclear Receptor CoRepressor (N-CoR) in the Presence of Mifepristone via Its N and C Termini Revealing a Novel Molecular Mechanism for Androgen Receptor Antagonists
2004
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Molecular evolution of the prostate cancer susceptibility locus RNASEL: Evidence for positive selection
2008
Alternative splicing and mutation status of CHEK2 in stage III breast cancer
2004
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
2004 Standout
Akt-regulated pathways in prostate cancer
2005
Microemulsion-based media as novel drug delivery systems
2000 Standout
Shared Principles in NF-κB Signaling
2008 Standout
Cross-talk between nuclear receptors and nuclear factor κB
2006
Androgen Receptor Phosphorylation
2002
Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis
2003
DJ-1 Positively Regulates the Androgen Receptor by Impairing the Binding of PIASxα to the Receptor
2001
Pathological and molecular aspects of prostate cancer
2003
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
Mutant and Wild-Type Androgen Receptors Exhibit Cross-Talk on Androgen-, Glucocorticoid-, and Progesterone-Mediated Transcription
1997
Androgen Receptor Defects: Historical, Clinical, and Molecular Perspectives*
1995
The development of androgen-independent prostate cancer
2001 Standout
Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1
2000
New advances in our understanding of the “unique” RNase L in host pathogen interaction and immune signaling
2016
A Testis-specific Androgen Receptor Coregulator That Belongs to a Novel Family of Nuclear Proteins
1999
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
2000 Standout
The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function
1994
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Increased telomerase activity and comprehensive lifestyle changes: a pilot study
2008 StandoutNobel
The Influence of Finasteride on the Development of Prostate Cancer
2003 Standout
Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer
2001
Androgen Receptor Gene Alterations in Finnish Male Breast Cancer
2003
New Paraoxonase 1 Polymorphism I102V and the Risk of Prostate Cancer in Finnish Men
2003
Male breast cancer
2006 Standout
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
Stress and the brain: from adaptation to disease
2005 Standout
Effects of vitamin C on androgen receptor mediated actions in human prostate adenocarcinoma cell line LAPC-4
2003
Chk2 Oligomerization Studied by Phosphopeptide Ligation
2008 StandoutNobel
Androgen-Insensitivity Syndrome as a Possible Coactivator Disease
2000
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
Prostate cancer and the androgen receptor: Strategies for the development of novel therapeutics
2000
Androgen receptor as a target in androgen-independent prostate cancer
2002
Inflammation in atherosclerosis
2002 StandoutNature
CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin?
2007
Differential expression of genes induced by resveratrol in LNCaP cells: P53‐mediated molecular targets
2003
Hormones and prostate cancer: Current perspectives and future directions
2002
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
Ligand-independent activation of steroid hormone receptors
1998
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Expression, structure, and function of androgen receptor in advanced prostatic carcinoma
1998
Production and Actions of Estrogens
2002 Standout
Activation of the Human Androgen Receptor through a Protein Kinase A Signaling Pathway
1996
RNase L: Its biological roles and regulation
2006
AR Possesses an Intrinsic Hormone-Independent Transcriptional Activity
2002
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
2004
Achieving transcriptional specificity with nf-κb
1997
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Mutations at the Boundary of the Hinge and Ligand Binding Domain of the Androgen Receptor Confer Increased Transactivation Function
2001
Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
1999
Roles of PPARs in health and disease
2000 StandoutNature
Thyroid Hormone-independent Interaction between the Thyroid Hormone Receptor β2 Amino Terminus and Coactivators
2000
Parkinson's Disease
2003 Standout
Integrating cell-signalling pathways with NF-κB and IKK function
2006 Standout
CREB Binding Protein Is a Coactivator for the Androgen Receptor and Mediates Cross-talk with AP-1
1998
STATs: transcriptional control and biological impact
2002 Standout
Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription
2000 StandoutNobel
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
Transcriptional regulation of adipogenesis
2000 Standout
Molecular Biology of the Androgen Receptor
2002
Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes.
1998
The coregulator exchange in transcriptional functions of nuclear receptors
2000 Standout
Cancer statistics in China, 2015
2016 Standout
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Activation of Androgen Receptor Function by a Novel Nuclear Protein Kinase
1998
Physiological and Molecular Basis of Thyroid Hormone Action
2001 Standout
Ligand-independent Activation of Steroid Receptors: New Roles for Old Players
1999
Mechanisms of Estrogen Action
2001 Standout
Androgen Receptor (AR) Coregulators: An Overview
2002
The Caenorhabditis elegans ARIP-4 DNA helicase couples mitochondrial surveillance to immune, detoxification, and antiviral pathways
2022 StandoutNobel
BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases
2007
Prevention of Hormone-Related Cancers: Prostate Cancer
2005
Collocation of androgen receptor gene mutations in prostate cancer.
2001
PIAS Proteins Modulate Transcription Factors by Functioning as SUMO-1 Ligases
2002
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
1999 Standout
A Dual Mechanism Mediates Repression of NF-κB Activity by Glucocorticoids
1998
Novel ATPase of SNF2-like Protein Family Interacts with Androgen Receptor and Modulates Androgen-dependent Transcription
2002
Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
2001
PKR-Dependent and -Independent Mechanisms Are Involved in Translational Shutoff during Sindbis Virus Infection
2004 StandoutNobel
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF
1997
Multiple Signal Input and Output Domains of the 160-Kilodalton Nuclear Receptor Coactivator Proteins
1999
Molecular Genetics and Epidemiology of Prostate Carcinoma
1999
Identification of a Novel RING Finger Protein as a Coregulator in Steroid Receptor-Mediated Gene Transcription
1998
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
2003 StandoutScience
Cloning and Characterization of Mouse RIP140, a Corepressor for Nuclear Orphan Receptor TR2
1998
The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression
2003
Steroid hormone receptors and their regulation by phosphorylation
1996
The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1
1999
Works of Tarja Ikonen being referenced
CHEK2 variants associate with hereditary prostate cancer
2003
Germline Alterations of the RNASEL Gene, a Candidate HPC1 Gene at 1q25, in Patients and Families with Prostate Cancer
2002
Dominant negative regulation of trans-activation by the rat androgen receptor: roles of the N-terminal domain and heterodimer formation.
1993
COMBINED IMMUNOSUPPRESSION WITH CYCLOSPORINE (NEORAL) AND SDZ RAD IN NON-HUMAN PRIMATE LUNG TRANSPLANTATION: SYSTEMATIC PHARMACOKINETIC-BASED TRIALS TO IMPROVE EFFICACY AND TOLERABILITY 1
2000
Interaction between the Amino- and Carboxyl-terminal Regions of the Rat Androgen Receptor Modulates Transcriptional Activity and Is Influenced by Nuclear Receptor Coactivators
1997
Heterodimerization is mainly responsible for the dominant negative activity of amino‐terminally truncated rat androgen receptor forms
1998
The presence of a transcription activation function in the hormone‐binding domain of androgen receptor is revealed by studies in yeast cells
1997
Androgen receptor CAG polymorphism and prostate cancer risk
2002
A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland
2001
Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation.
1994
Mutual Transcriptional Interference between RelA and Androgen Receptor
1996
ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.
2001
Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation
1994